Diabetic Foot Ulcer Treatment Market Analysis

  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Diabetic Foot Ulcer Treatment Market Analysis

Ulcer Type (Neuropathic Ulcer, Ischemic Ulcer, Neuro-Ischemic Ulcer)

The global diabetic foot ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer. Among these segments, the neuropathic ulcer segment is anticipated to capture the largest market size in the global diabetic foot ulcer treatment market owing to an increase in peripheral neuropathy cases among diabetics. It was observed that approximately 48% of diabetic patients experience peripheral neuropathy at some point in their lives, with prevalence ranging from 7% to 50% based on factors such as diabetes type and glycemic control. Furthermore, the number of risks associated with neuropathic ulcers, such as infection, amputation, and death, and increasing treatment options for ulcer diagnosis is projected to augment segment growth over the forecast period.

End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare)

The global diabetic foot ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and homecare. Amongst these four segments, the hospital segment is expected to garner a significant share. The patient suffering with diabetic ulcers should be taken to hospitals, as ulcers can lead to severe infection and it can increase the risk of amputation. Therefore, to avoid the stage of amputation, the patient should be given immediate care of the hospital for dealing with complicated ulcers. The properly trained staff of the hospital can provide intensive care and the patient can be treated with multiple services present in the hospital.

Our in-depth analysis of the global market includes the following segments:

By Ulcer Type

  • Neuropathic Ulcer
  • Ischemic Ulcer
  • Neuro-Ischemic Ulcer

By Product

  • Wound-Care Dressings
  • Wound-Care Devices
  • Active Therapies
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4603
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic foot ulcer treatment is evaluated at USD 2.37 billion.

The diabetic foot ulcer treatment market size was valued at USD 2.26 billion in 2024 and is likely to exceed USD 4.93 billion by the end of 2037, registering over 6.3% CAGR during the forecast period i.e., between 2025-2037. An increase in sedentary lifestyles, surge in number of people suffering from type 2 diabetes along with increasing obesity among people will boost the market growth.

North America is projected to hold largest industry share by 2037, attributed to ulcer type into a neuropathic ulcer, ischemic ulcer, and neuro-ischemic ulcer.

The major players in the market include UPM, Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample